{"meta":{"query_hash":"b0be9f2b761b","filters":{"venue":"Neoplasma"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b0be9f2b761b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neoplasma"},"results":[{"id":"W2318561906","doi":"10.4149/neo_2010_06_590","title":"Endoglin and CD-34 immunoreactivity in the assessment of microvessel density in normal pituitary and adenoma subtypes","year":2010,"lang":"en","type":"article","venue":"Neoplasma","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Endoglin; Angiogenesis; Pathology; Immunohistochemistry; Adenoma; Pituitary adenoma; CD34; Pituitary tumors; Microvessel; Pituitary neoplasm; Medicine; Pituitary gland; Internal medicine; Biology; Hormone","score_opus":0.0066556922757678195,"score_gpt":0.25213864238706885,"score_spread":0.24548295011130103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318561906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992231,0.00040326887,0.00019386206,0.0000049720866,0.0000010490527,0.00000320144,0.00001539663,0.000001825483,0.00015329653],"genre_scores_gemma":[0.99933535,0.00012754343,0.00036247668,0.0000041635312,0.0000027607398,0.0000053585904,0.00003537668,6.544911e-7,0.000126329],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986446,0.00003293136,0.000013978845,0.000024158026,0.000040644485,0.000023858434],"domain_scores_gemma":[0.99974984,0.00009126493,0.0000659608,0.000012380187,0.000038730224,0.00004182691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038727967,0.000098603035,0.00009035713,0.00063260156,0.00012353904,0.00013155937,0.00009347436,0.00014021099,0.0006692424],"category_scores_gemma":[0.0005539279,0.000084123334,0.00006829093,0.00017771158,0.00024843254,0.00016478145,0.00013432495,0.00009432463,0.00006551547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002151925,0.00009364693,0.5979885,0.000100929545,0.000052689513,0.00057176285,0.00032539997,0.00015230752,0.3816314,0.00010018299,0.00007515104,0.01675622],"study_design_scores_gemma":[0.000025188183,0.00087320793,0.9594724,0.0000085093625,0.00004996963,0.003981059,0.00030242038,0.000662537,0.033824064,0.00009031615,0.0007028833,0.000007431835],"about_ca_topic_score_codex":0.0008737056,"about_ca_topic_score_gemma":0.001396854,"teacher_disagreement_score":0.0008737056,"about_ca_system_score_codex":0.00015064568,"about_ca_system_score_gemma":0.00007694399,"threshold_uncertainty_score":0.00223881},"labels":[],"label_agreement":null},{"id":"W2886880347","doi":"10.4149/neo_2018_170822n551","title":"TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis","year":2018,"lang":"en","type":"article","venue":"Neoplasma","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Natural Science Foundation of China","keywords":"Prostate cancer; Medicine; Biomarker; Clinical significance; Oncology; Metastasis; Internal medicine; Biochemical recurrence; Logistic regression; Cancer; Prostatectomy; Biology","score_opus":0.046944165663513567,"score_gpt":0.3831711671102199,"score_spread":0.33622700144670636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886880347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393552,0.04954871,0.0063899257,0.0006814809,0.000121052544,0.000068524416,0.0010955943,0.00020504177,0.002534508],"genre_scores_gemma":[0.9905629,0.0046788347,0.002811317,0.00012990438,0.00007772466,0.000032333133,0.00075109035,0.000009718626,0.00094616617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976414,0.000054311506,0.000019578338,0.00005847231,0.000070530594,0.00003297073],"domain_scores_gemma":[0.9997727,0.000035679346,0.00010002284,0.0000145814865,0.00003865661,0.000038440485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063700817,0.00034278166,0.00041993667,0.0008927547,0.00018919066,0.0006992695,0.00019751808,0.0003955614,0.0011832104],"category_scores_gemma":[0.00054235937,0.00023377824,0.00032700392,0.0006641428,0.00021995485,0.00037867166,0.0002696521,0.0004528271,0.0003223578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022740092,0.0002329537,0.5327614,0.0008111002,0.0004777074,0.0005985037,0.00014082756,0.0015637244,0.32369637,0.0009542461,0.003219908,0.13326931],"study_design_scores_gemma":[0.000083866325,0.0010673029,0.8635016,0.00012180481,0.00051066757,0.003954254,0.0002005198,0.016073292,0.09053359,0.0012621402,0.022641988,0.000048924583],"about_ca_topic_score_codex":0.0004311588,"about_ca_topic_score_gemma":0.00065805303,"teacher_disagreement_score":0.0011832104,"about_ca_system_score_codex":0.00024277248,"about_ca_system_score_gemma":0.00015720374,"threshold_uncertainty_score":0.0039582253},"labels":[],"label_agreement":null},{"id":"W2980342814","doi":"10.4149/neo_2019_190309n203","title":"Chromosome 17 centromere amplification and chromosomal instability (CIN) in breast cancer: Pathogenic and therapeutic implications","year":2019,"lang":"en","type":"article","venue":"Neoplasma","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital; Essar Steel Algoma (Canada); NOSM University","funders":"","keywords":"Centromere; Polysomy; Chromosome instability; Breast cancer; Biology; Cancer; Gene duplication; Chromosome; Aneuploidy; Genetics; Cancer research; Oncology; Medicine; Fluorescence in situ hybridization; Gene","score_opus":0.006784070859695528,"score_gpt":0.21908607782741657,"score_spread":0.21230200696772103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980342814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5954999,0.3879618,0.0015765531,0.0052691754,0.00012522265,0.00001614665,0.00019435171,0.000041846888,0.009315006],"genre_scores_gemma":[0.92443895,0.07367901,0.00068834703,0.00015984497,0.0001746506,0.000005506555,0.000060655784,0.000004515237,0.00078840123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998925,0.000042527045,0.0000075954235,0.00001552922,0.000024383547,0.000017384671],"domain_scores_gemma":[0.9997992,0.00007745619,0.000068106216,0.000006587161,0.00002091045,0.000027872264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034238107,0.00018297727,0.00016726696,0.0011151934,0.00020320695,0.00052735826,0.00021337932,0.00043597017,0.0014085163],"category_scores_gemma":[0.0007176481,0.00008367458,0.00008739943,0.00098974,0.00048714757,0.00036529737,0.00026094986,0.00028132132,0.00018602364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013965048,0.00019423237,0.57710224,0.001449104,0.00017059034,0.013574961,0.00077158434,0.001271281,0.03995491,0.007409085,0.0029491507,0.3537563],"study_design_scores_gemma":[0.000039591927,0.0005467504,0.8571004,0.0006586608,0.0003089016,0.06543953,0.002068752,0.0021407898,0.012210312,0.011349483,0.04807605,0.000060786955],"about_ca_topic_score_codex":0.0006580314,"about_ca_topic_score_gemma":0.000788598,"teacher_disagreement_score":0.0014085163,"about_ca_system_score_codex":0.00034982557,"about_ca_system_score_gemma":0.0003296803,"threshold_uncertainty_score":0.0047119856},"labels":[],"label_agreement":null},{"id":"W2980900961","doi":"10.4149/neo_2019_190110n34","title":"Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review","year":2019,"lang":"en","type":"review","venue":"Neoplasma","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Repurposing; Breast cancer; Triple-negative breast cancer; Oncology; Drug repositioning; Internal medicine; Clinical trial; In vivo; Cancer; Metastasis; Observational study; Drug; Pharmacology","score_opus":0.07109275791822826,"score_gpt":0.36846849762571493,"score_spread":0.29737573970748665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980900961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076214166,0.99814117,0.00008810285,0.00017385522,0.000083056664,0.00015096899,0.00033581696,0.000005427732,0.00025945346],"genre_scores_gemma":[0.010127198,0.9884319,0.00033111806,0.00042475344,0.0000750862,0.0002757699,0.000240919,0.0000044056387,0.00008896967],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99497944,0.0015160262,0.002238805,0.00033528966,0.00078109885,0.00014940226],"domain_scores_gemma":[0.9764445,0.017118193,0.004066301,0.00025991077,0.0018550121,0.00025624802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053660213,0.0012888919,0.008088365,0.008672329,0.00051447505,0.0023214002,0.0018891682,0.001963281,0.006033359],"category_scores_gemma":[0.025580624,0.00082334614,0.007111197,0.008415846,0.0007111233,0.001677875,0.0012000181,0.00093448616,0.00044433717],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018953532,0.000010294666,0.00036979053,0.97199655,0.0063422364,0.000068999696,0.000077340585,0.000048573846,0.0001246386,0.00009951528,0.00082550186,0.019847054],"study_design_scores_gemma":[0.00028753237,0.00020777957,0.002827151,0.8923383,0.08702329,0.0003190421,0.00016760342,0.000061208026,0.00017045788,0.0001956756,0.016374085,0.000028013214],"about_ca_topic_score_codex":0.005356638,"about_ca_topic_score_gemma":0.01530882,"teacher_disagreement_score":0.008672329,"about_ca_system_score_codex":0.0022246183,"about_ca_system_score_gemma":0.0069531524,"threshold_uncertainty_score":0.028378606},"labels":[],"label_agreement":null},{"id":"W3189694561","doi":"10.4149/neo_2021_210205n180","title":"Alpha-fetoprotein/endoplasmic reticulum stress signaling mitigates injury in hepatoma cells","year":2021,"lang":"en","type":"article","venue":"Neoplasma","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chinese Foundation for Hepatitis Prevention and Control; Petroleum Technology Research Centre; National Natural Science Foundation of China","keywords":"Unfolded protein response; Endoplasmic reticulum; Thapsigargin; Apoptosis; Necroptosis; Gene knockdown; Cell biology; Chemistry; Programmed cell death; Cell growth; Alpha-fetoprotein; Cancer research; Biology; Molecular biology; Hepatocellular carcinoma; Biochemistry","score_opus":0.00434639496520042,"score_gpt":0.22212228899172826,"score_spread":0.21777589402652783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189694561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108315,0.0031790677,0.003390491,0.00015544175,0.000046592562,0.000035836976,0.00019253492,0.00012591372,0.0017909537],"genre_scores_gemma":[0.99387735,0.0019209331,0.0016185732,0.00006859534,0.00001251155,0.000027313878,0.00028713845,0.000009630687,0.002177833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999943,0.000011908881,0.0000055471037,0.000009209932,0.000013340392,0.000016928112],"domain_scores_gemma":[0.99997115,0.0000040869277,0.000006821827,0.0000033856688,0.0000060635653,0.0000084908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009517918,0.0002954778,0.00025564936,0.00018729384,0.00013737127,0.00019442604,0.000075443495,0.00015591916,0.0006610693],"category_scores_gemma":[0.0000499052,0.00007759795,0.00018724262,0.00017570067,0.000115154304,0.00019684671,0.00015043381,0.00035229232,0.00020129915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015855228,0.000022927305,0.00017189626,0.0000364927,0.0000046778496,0.00009285656,0.0000149237485,0.000037550843,0.99788207,0.00005012729,0.000041042524,0.0014867957],"study_design_scores_gemma":[0.00002988922,0.00045111388,0.0056155394,0.000006113677,0.00002730757,0.00036269767,0.00007786015,0.00088093814,0.9895682,0.00007960696,0.002896355,0.0000044353965],"about_ca_topic_score_codex":0.00053227646,"about_ca_topic_score_gemma":0.0008818629,"teacher_disagreement_score":0.0006610693,"about_ca_system_score_codex":0.00014711959,"about_ca_system_score_gemma":0.00015733916,"threshold_uncertainty_score":0.0022115111},"labels":[],"label_agreement":null}]}